Netherlands Reveals Top-Scoring Pharmaceutical Industry Products in Foreign Supply Chain

The Netherlands has disclosed insights into its foreign pharmaceutical supply chain, highlighting products that have achieved exceptional scores in terms of both import value and global significance. These findings are based on an analysis of data from the year 2019 and shed light on the dynamics of international trade in the pharmaceutical sector.

The report underscores products that have garnered the highest scores in various dimensions, including import value, global market share, import concentration, import diversification, and other vital metrics. Among the standout products are:

  1. Iron Ore: Sourced from Australia, with China as its primary producer, this product achieved a remarkable score of 10. The Netherlands imported a substantial volume, indicating a strong presence in the global market.
  2. Specific Amino Acids: Singapore is the point of origin for these chemicals, with Belgium being the recipient. This product garnered a score of 9, signifying its significant role in the pharmaceutical supply chain.
  3. Alkanes: With the United States as its producing country, this chemical compound exhibited a score of 9. Its primary user is the United Kingdom, further emphasizing its significance.
  4. Soybeans: Originating from the United States and Brazil, these agricultural products made an impact with a score of 9. Germany and China emerged as the primary users.

The analysis not only delves into the scores and import values but also offers insights into market concentration, import diversification, and other relevant factors that influence the pharmaceutical supply chain’s dynamics.

The Dutch pharmaceutical industry’s engagement with global markets is underscored by these findings, shedding light on the products that play a pivotal role in the international pharmaceutical trade landscape. The report’s comprehensive data and insights provide a valuable resource for stakeholders seeking to understand and navigate the intricacies of pharmaceutical supply chains.